Boyle James M

Chief Executive Officer, DirectorMedline Inc. (MDLN) · full profile →Form 4 · filed Mar 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
3 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Grant(A)32K$032K
Dec 16, 2025Grant(A)515K515K
Dec 16, 2025Grant(A)24K24K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Grant(A)515K515K
Dec 16, 2025Grant(A)1.1M1.1M
Dec 16, 2025Grant(A)1.2M1.2M
Dec 16, 2025Grant(A)252K252K
Dec 16, 2025Grant(A)184K184K
Dec 16, 2025Grant(A)340K340K
Dec 16, 2025Grant(A)1.1M1.1M
Dec 16, 2025Grant(A)24K24K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096654) within minutes of acceptance. Every field above traces to the original document. Verify it directly: